Supplemental Screening for Dense Breasts: MRI, CEM, ABUS
Part 2 of our Breast Cancer Awareness Month series
You found your lane. Now what?
Welcome back! In Part 1, we sorted out the two big questions behind your screening plan: how dense your breast tissue is, and what your lifetime risk of breast cancer is. Quick recap:
Average risk: a yearly mammogram starting at 40.
Dense breasts (category C or D): that yearly mammogram, plus a conversation about adding a second test.
High risk (lifetime risk of 20% or more on a model like Tyrer-Cuzick): a yearly mammogram and a yearly MRI, often staggered six months apart.
Haven’t calculated your risk score yet? Part 1 shows you how.
Today we’re tackling the part that makes most women’s eyes glaze over: the extra tests themselves, with names that sound like a robot’s alphabet (ABUS! CEM! AB-MRI!), and the even more exciting question of who pays for them. Stay with us. There’s a cheat sheet at the end.
Meet the supplemental screening lineup for dense breasts
A supplemental test is a second look that can find what a mammogram might miss in dense tissue. It’s added to your mammogram, not used instead of it. The American College of Radiology (2023) recommends breast MRI for women with dense breasts who want supplemental screening, and says contrast-enhanced mammography or ultrasound can be considered when MRI isn’t possible (ACR recommendations, Monticciolo et al.).
Here are your main contenders:
Ultrasound, including automated breast ultrasound (ABUS). No radiation, no needles, no contrast dye, and widely available. With ABUS, a machine sweeps a wide probe over your breast to create 3D images. In the large SomoInsight study, adding ABUS to mammograms in women with dense breasts found about 1.9 extra cancers per 1,000 women. The downside was a lot of callbacks for findings that turned out to be benign (Brem et al., Radiology 2015).
Abbreviated breast MRI. The “express lane” version of a full breast MRI: shorter, faster, and less expensive, with contrast dye given through an IV. In women with dense breasts, it found 11.8 invasive cancers per 1,000 women, compared with 4.8 for 3D mammography (Comstock et al., JAMA 2020).
Contrast-enhanced mammography (CEM). The mammogram’s overachieving cousin. It gets its own spotlight below, because it deserves one.
Plot twist: why extremely dense breasts (category D) change the game
This part surprises a lot of women: for very dense tissue, ultrasound may not be the strongest add-on. Two major studies explain why.
The DENSE trial (Netherlands, 2019) followed more than 40,000 women with extremely dense breasts (category D) and normal mammograms. Adding MRI cut “interval cancers” (cancers found between screenings) roughly in half, from 5.0 to 2.5 per 1,000 women. The trade-off: about 8% of MRIs led to a false alarm (Bakker et al., NEJM 2019, via AAFP summary).
The BRAID trial (United Kingdom, 2025) put the tests head to head in more than 9,000 women with dense breasts and normal mammograms. Per 1,000 women, contrast-enhanced mammography found about 19 cancers, abbreviated MRI about 17, and ABUS about 4. The cancers found with contrast imaging were also about half the size (Gilbert et al., Lancet 2025, via HealthDay).
ABUS is far better than nothing, and it’s a reasonable choice when MRI or contrast isn’t available or isn’t right for you. But the denser your tissue, the stronger the case for a contrast-based test like MRI or CEM. For category D, that’s where the best evidence points.
One honest caveat: finding more cancers isn’t exactly the same as saving more lives. Some extra cancers found may grow slowly enough that they’d never cause harm. Researchers are still following these women to answer that question.
Contrast-enhanced mammography (CEM), up close
Contrast-enhanced mammography (CEM) is a regular mammogram with one added step: an IV injection of iodine-based contrast dye, the same kind used for CT scans. Cancers tend to grow extra blood vessels, so they “light up” with contrast even when dense tissue would otherwise hide them.
What a contrast-enhanced mammogram is actually like
If you’ve had a mammogram, most of this will feel familiar:
A small IV goes in your arm, and the contrast dye is injected. Some women notice a brief warm feeling.
About two minutes later, you’re positioned for a mammogram just like usual, same compression and all.
For each view, the machine takes two pictures in a single squeeze: a low-energy image and a high-energy image. All the pictures are finished within about 10 minutes of the injection, while the contrast is still doing its job (Radiopaedia).
Software combines the two. You end up with a regular-looking mammogram plus a “recombined” image where normal tissue fades into the background and areas that soak up contrast stand out (review, PMC).
That second image is what makes CEM so useful. Dense tissue that can hide things on a regular mammogram mostly fades away, and areas with extra blood flow, which is how many cancers behave, light up. It works on the same principle as breast MRI, just with x-rays instead of a giant magnet.
CEM was first FDA-approved in 2011 as an add-on to mammography, mostly for diagnostic workups (review, PMC). Using it for routine screening is newer and growing quickly as evidence like the BRAID trial rolls in. The ACR specifically names CEM as an option for women who should get supplemental screening but can’t have an MRI (ACR press release).
Contrast-enhanced mammography vs. breast MRI at a glance
| Contrast-enhanced mammography | Breast MRI | |
| Contrast dye | Iodine (same as CT) | Gadolinium |
| Radiation | Yes; about 30% more than a standard digital mammogram in one two-center study (Cancers, 2022) | None |
| Time | About as long as a mammogram, plus the IV | Longer; abbreviated MRI shortens it |
| Position | Standing, with compression | Lying face down in a tube |
| Good fit if | MRI isn’t possible: claustrophobia, some implanted devices, access, or cost | You qualify and can have it; the most studied option for high-risk screening |
| Not a fit if | Prior serious reaction to iodine contrast, significant kidney disease, or pregnancy | Some implanted devices, severe claustrophobia, or gadolinium concerns |
In BRAID, about 1.2% of women had some reaction to the CEM contrast, most of them minor (AuntMinnie coverage). CEM also isn’t offered everywhere yet, so availability near you may vary.
And now, the final boss: insurance coverage
By now you know your density, your risk score, and which test might fit. That leaves your insurance plan, and if the rules make your head spin, you’re far from the only one. If deductibles and coinsurance still feel fuzzy, our guide to understanding your insurance benefits covers the basics.
Here’s why it’s so tangled.
Screening and diagnostic have historically been treated very differently. Your yearly screening mammogram is generally covered as preventive care with no out-of-pocket cost at an in-network facility. But if you got called back for more pictures, that follow-up was often billed as “diagnostic,” which meant deductibles and coinsurance. A federal update to the Women’s Preventive Services Guidelines, approved in December 2024, changed this for most private plans starting with 2026 plan years: additional imaging (like MRI, ultrasound, or more mammogram views) and biopsies needed to complete the screening process, plus patient navigation services, should now be covered without cost sharing in-network (Federal Register notice; plain-language summary). How each plan applies this to routine supplemental screening still varies.
Supplemental screening coverage depends on where you live and what plan you have. Many states have passed laws requiring insurers to cover supplemental breast imaging, sometimes with no out-of-pocket cost. But every state’s law is different. They vary on which tests count (MRI, contrast-enhanced mammography, ultrasound), who qualifies (some include all dense breasts, some only extremely dense breasts, some only women at higher risk), how many tests per year are covered, and whether you’ll owe a copay or deductible. Some states have no law at all (DenseBreast-info state-by-state summary). So before you schedule anything, call your plan.
Your type of plan matters as much as your state. A state’s law only reaches the plans that state regulates. If your employer pays claims itself (called a self-funded plan, and common at larger companies), if your policy was issued in another state, or if you’re covered through Medicare or TRICARE, your state’s rules may not apply (DenseBreast-info). Many women don’t know which kind of plan they have until they ask.
Prior authorization is still a thing. Even when a test is covered, many plans require approval before an MRI or contrast study, and they may require an in-network imaging center.
What about Idaho and Montana?
Most of our patients live in Idaho or Montana, and the two states handle this differently. These laws only cover state-regulated plans, not self-funded employer plans, so check your plan type first.
Idaho. Starting January 1, 2026, Idaho law requires state-regulated health plans to cover one supplemental breast screening every year with no deductible, copay, or coinsurance at an in-network provider (Idaho Department of Insurance). Covered tests are breast MRI (full or abbreviated) and contrast-enhanced mammography, with ultrasound when those aren’t possible. You qualify if you have:
Extremely dense breasts (category D)
A lifetime risk over 20% on a family-history-based risk model like Tyrer-Cuzick
A personal history of breast cancer, or atypical cells on a breast biopsy
A family history of breast cancer
A genetic predisposition, such as a BRCA1 or BRCA2 mutation
Prior radiation therapy to the chest
Heterogeneously dense breasts (category C) count only when paired with one of a few specific risk factors, such as a BRCA mutation in you or an untested first-degree relative, or chest radiation between ages 10 and 30. So in Idaho, category C on its own usually won’t qualify you for the no-cost benefit. Your plan may still cover a supplemental test with your usual deductible or copay, so ask. Idaho Medicaid isn’t included.
Montana. Since October 2023, Montana law has barred state-regulated plans, with a few exceptions, from charging a deductible, copay, or coinsurance for diagnostic breast imaging or for supplemental breast exams with MRI or ultrasound when they’re medically necessary based on your personal or family history or other risk factors (Montana Code § 33-22-132). The law doesn’t name contrast-enhanced mammography, so if CEM is on the table, ask your plan directly.
In either state, if you think a claim was handled wrong, the state insurance department’s consumer help team can step in.
What to ask your insurance before you schedule
About your plan
Is my plan fully insured or self-funded? (Your HR or benefits office can tell you. Self-funded plans often don’t have to follow state insurance laws.)
Does my state have a breast imaging coverage law, and does it apply to my plan?
About coverage
Is supplemental breast screening covered for someone with my breast density and risk level?
Which tests are covered: breast MRI, abbreviated MRI, contrast-enhanced mammography, or ultrasound (including automated breast ultrasound)?
How many supplemental screenings are covered per year?
Will it be billed as preventive (screening) or diagnostic, and does it count toward my deductible?
What will I owe out of pocket: copay, coinsurance, or deductible?
If I’m called back after a screening mammogram, is the follow-up imaging covered without cost sharing?
About the process
Do I need prior authorization, and who submits it?
What documentation do you need, such as my density category or risk score?
Which imaging centers near me are in-network for this specific test?
Pro tips for the call
Ask the imaging center for the billing code (called a CPT code) for your test, and give it to your insurance. You’ll get a much more precise answer.
Write down the date, the representative’s name, and a reference number for the call.
If a claim gets denied, ask how to appeal. Denials can be overturned, and your provider’s office can often help with supporting documentation.
If the answers come back muddled (and sometimes they do), bring them to your next appointment, and your care team can help you sort through it.
Why all of this matters (plus your cheat sheet)
When breast cancer is caught early, it’s usually smaller and easier to treat, and survival is better. A mammogram is still the foundation for everyone. But for women with dense breasts or higher risk, the right second test can catch what the first one misses, and the right questions can keep a surprise bill out of your mailbox.
| Your situation | Supplemental tests to discuss | Notes |
| Dense (C), average risk | MRI (often abbreviated), CEM, or ultrasound/ABUS | Coverage varies widely by state and plan; call before scheduling |
| Extremely dense (D) | MRI or CEM preferred; ultrasound if those aren’t possible | Strongest evidence for contrast-based tests |
| High risk (20% or more) | Yearly MRI, often staggered 6 months from your mammogram | CEM if you can’t have MRI; prior authorization is often required |
| Can’t have MRI but would qualify | CEM, or ultrasound | Ask about CEM availability near you |
Your next steps:
Know your density letter and your lifetime risk (missed Part 1? Start there).
Talk with your provider about whether a supplemental test fits you, and which one.
Run through the insurance questions above before you schedule.
Keep your yearly mammogram on the calendar, even if you add a second test.
Your primary care provider, gynecologist, and breast imaging team are all part of this, and at Illumination Women’s Health, we’d love to help you put the pieces together too. Bring your density letter, your risk score, and your insurance answers to the conversation, and we’re always happy to help you choose a plan that feels informed instead of overwhelming. When you’re ready, you can schedule a visit online.
Frequently asked questions about supplemental breast screening
What is supplemental breast cancer screening?
It’s a second screening test added to your yearly mammogram to catch what the mammogram might miss, especially in dense breast tissue or for women at higher risk. It doesn’t replace your mammogram. The main options are breast MRI (full or abbreviated), contrast-enhanced mammography, and ultrasound, including automated breast ultrasound (ABUS).
What is the best supplemental screening test for dense breasts?
The American College of Radiology recommends breast MRI for women with dense breasts who want supplemental screening, with contrast-enhanced mammography or ultrasound as options when MRI isn’t possible. For extremely dense breasts, the strongest evidence points to contrast-based tests. In the BRAID trial of women with dense breasts, MRI and contrast-enhanced mammography found roughly four times as many cancers as automated breast ultrasound.
What is contrast-enhanced mammography?
Contrast-enhanced mammography (CEM) is a mammogram done after an IV injection of iodine-based contrast dye. Many cancers grow extra blood vessels, so they light up on the contrast images even when dense tissue would hide them on a regular mammogram. It feels a lot like a standard mammogram, plus a small IV.
Does insurance cover supplemental breast screening?
It depends on your state, your plan type, and your risk level. Many states require some coverage, but the rules vary, and state laws generally don’t apply to self-funded employer plans. In Idaho, state-regulated plans must cover one supplemental screening a year at no cost in-network for women who meet certain risk criteria. Montana bars cost sharing for medically necessary supplemental MRI or ultrasound. Either way, call your plan before you schedule.
Will I pay for follow-up imaging after a mammogram callback?
For most private plans starting with 2026 plan years, updated federal guidelines say additional imaging needed to complete the screening process should be covered without cost sharing at in-network facilities. How each plan applies this still varies, so it’s worth confirming with your insurance.
This post is for general education and isn’t a substitute for personal medical advice. Talk with your provider about what’s right for you.
Keep reading
Dense Breasts and Risk Scores: Which Screening Lane Are You In?: Part 1, on finding your density letter and calculating your risk score
Understanding Your Insurance Benefits: what to check when your plan resets, and how we can help
